On Thursday, Shares of Vonage Holdings Corp. (NYSE:VG), gained 3.71% to $28.87.
Vonage Holdings Corp., has designated Omar Javaid as Chief Product Officer. Mr. Javaid will join the Company on August 3 and report to Chief Executive Officer Alan Masarek.
Mr. Javaid will be responsible for the Company’s overall product strategy. He will work with teams across the organization to define and execute Vonage’s product roadmap for Consumer Services and Vonage Business.
Vonage Holdings Corp. provides unified communications as a service solutions connecting people through cloud-connected devices worldwide. The company offers home telephone replacement services to residential customers through various service plans with basic features, such as voicemail, call waiting, call forwarding, simulring, visual voicemail, and extensions, in addition to area code selection, virtual phone number, and Web-enabled voicemail.
Shares of United Parcel Service, Inc. (NYSE:UPS), inclined 0.31% to $97.48, during its last trading session.
UPS Capital(R), a partner of UPS which provides supply chain financial, insurance and payment solutions, declared that it is purchasing the Insured Parcel Services (IPS) business of G4S International Logistics (G4Si), the logistics arm of G4S, the world’s leading global integrated security company. UPS Capital recently attained Parcel ProTM, the leading logistics provider to the high-value jewelry, wristwatch and collectibles industries. With this acquisition, IPS customers will have access to improved service offerings through Parcel Pro’s secure logistics solutions, counting higher insured value limits, expanded international coverage and superior technology.
Customers of the Insured Parcel Services unit of G4Si that is being attained by UPS Capital will continue to receive the excellent service and protection they have come to expect. They will benefit from everything UPS Capital and Parcel Pro bring to the table, counting significantly improved technology capabilities, such as mobile apps, API (application program integration) and risk administration web tools. They also will receive coverage up to $150,000 per package in the United States and up to $100,000 in other select countries.
United Parcel Service, Inc., a package delivery company, provides transportation, logistics, and financial services in the United States and internationally. It operates in three segments: U.S. Domestic Package, International Package, and Supply Chain & Freight.
At the end of Thursday’s trade, Shares of Fulton Financial Corp (NASDAQ:FULT), lost - 0.33% to $13.45.
Fulton Financial Corporation (NASDAQ: FULT) declared that it will distribute its second quarter 2015 earnings news release and accompanying charts on Tuesday, July 21 at about 4:30 p.m. Eastern Time.
The Corporation will host its quarterly conference call with analysts who cover the company on Wednesday, July 22 at 10 a.m. Eastern Time.
Fulton Financial Corporation operates as a multi-bank financial holding company that provides a range of banking and financial services to businesses and consumers. It offers personal banking services that comprise various checking account and savings deposit products, certificates of deposit, and individual retirement accounts.
Finally, Valeant Pharmaceuticals Intl Inc (NYSE:VRX), ended its last trade with 1.28% gain, and closed at $238.85.
Eyegate Pharmaceuticals, declared that it has reached an exclusive, worldwide licensing agreement with a partner of Valeant Pharmaceuticals International, Inc. (VRX) (VRX) through which EyeGate has granted Valeant exclusive, worldwide commercial and manufacturing rights to its EyeGate(R) II Delivery System and EGP-437 combination product in the field of uveitis, in addition to a right of last negotiation to license the Product for other indications.
Under the agreement, EyeGate will receive an upfront cash payment, development-based milestone payments related to the completion of development for the indication of anterior uveitis and an approval-based milestone payment upon receipt of FDA approval of the Product. Additionally, the Company would receive royalties based on net sales, in addition to additional milestone payments based on the achievement of certain cumulative sales milestones. EyeGate shall be responsible for the development of the Product in the U.S. for the indication of anterior uveitis, together with the costs associated therewith. Valeant has the right to develop the Product in the field outside of the U.S. and has agreed to fund 100% of any costs associated therewith.
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
